Literature DB >> 20596634

Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis.

Huiyan Niu1, Hui Li, Can Xu, Ping He.   

Abstract

Rho GDP dissociation inhibitors (RhoGDIs) are important regulators of the GTP hydrolase activity and biological functions of Rho GTPases. RhoGDI2 has been shown to be a metastasis suppressor in bladder cancer and several other cancers. However, the underlying mechanism, effector targets, and the cognate biological functions of RhoGDI2 are not fully understood. To investigate the possible role of RhoGDI2 in lung cancer tumorigenesis and metastasis, the expression pattern of RhoGDI2 in various lung cancer tissue samples and lung cancer-derived cell lines were profiled at both mRNA and protein levels. Furthermore, possible interplay between PI3K/Akt/mTOR pathway activation/inhibition and RhoGDI2 signalling is examined in lung cancer-related cell lines. Our results suggest that RhoGDI2 is likely to be involved in lung tumor malignancy and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596634     DOI: 10.3892/or_00000880

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma.

Authors:  Haifeng Wang; Jiansong Wang; Yigang Zuo; Mingxia Ding; Ruping Yan; Delin Yang; Changxin Ke
Journal:  Med Oncol       Date:  2011-07-14       Impact factor: 3.064

2.  Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Ashley R Murray; Ann Hubbs; Madalina M Chirila; Phouthone Keohavong; Lyudmila P Sycheva; Valerian E Kagan; Vincent Castranova
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

3.  RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.

Authors:  Huiyan Niu; Baogang Wu; Yang Peng; Hongfang Jiang; Yi Zhang; Jiahe Wang; Yifei Zhang; Ping He
Journal:  Tumour Biol       Date:  2014-09-30

4.  Lentivirus vector-mediated Rho guanine nucleotide dissociation inhibitor 2 induces beta-2 adrenergic receptor desensitization in β2AR desensitization mice model.

Authors:  Songshi Ni; Jing Zhao; Zhenxue Fu; Hua Liu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

5.  XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.

Authors:  Yonghui Yu; Honglei Jin; Jiheng Xu; Jiayan Gu; Xin Li; Qipeng Xie; Haishan Huang; Jingxia Li; Zhongxian Tian; Guosong Jiang; Caiyi Chen; Feng He; Xue-Ru Wu; Chuanshu Huang
Journal:  Int J Cancer       Date:  2017-12-28       Impact factor: 7.396

Review 6.  Targeting Cdc42 in cancer.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Expert Opin Ther Targets       Date:  2013-08-19       Impact factor: 6.902

7.  RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus.

Authors:  Min-Hee Yi; Kisang Kwon; Enji Zhang; Je Hoon Seo; Sang Soo Kang; Chang-Gue Son; Joon Won Kang; Dong Woon Kim
Journal:  Cell Mol Neurobiol       Date:  2014-10-02       Impact factor: 5.046

8.  BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.

Authors:  Peter R Bucciarelli; Kay See Tan; Neel P Chudgar; Whitney Brandt; Joseph Montecalvo; Takashi Eguchi; Yuan Liu; Rania Aly; William D Travis; Prasad S Adusumilli; David R Jones
Journal:  J Thorac Oncol       Date:  2017-10-31       Impact factor: 15.609

9.  RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.

Authors:  Erin M Griner; Garrett M Dancik; James C Costello; Charles Owens; Sunny Guin; Michael G Edwards; David L Brautigan; Dan Theodorescu
Journal:  Mol Cancer Res       Date:  2014-12-16       Impact factor: 5.852

10.  Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.

Authors:  Mikkel G Terp; Kirstine Jacobsen; Miguel Angel Molina; Niki Karachaliou; Hans C Beck; Jordi Bertran-Alamillo; Ana Giménez-Capitán; Andrés F Cardona; Rafael Rosell; Henrik J Ditzel
Journal:  NPJ Precis Oncol       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.